Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans

Background/Objectives: Marburg virus (MARV) is the etiological agent of Marburg Virus Disease (MVD), a rare but severe hemorrhagic fever disease with high case fatality rates in humans. Smaller outbreaks have frequently been reported in countries in Africa over the last few years, and confirmed huma...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alina Tscherne, Georgia Kalodimou, Alexandra Kupke, Cornelius Rohde, Astrid Freudenstein, Sylvia Jany, Satendra Kumar, Gerd Sutter, Verena Krähling, Stephan Becker, Asisa Volz
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2024-11-01
Col·lecció:	Vaccines
Matèries:	Modified Vaccinia virus Ankara (MVA) viral vector vaccine emerging viruses rapid vaccine development Marburg virus
Accés en línia:	https://www.mdpi.com/2076-393X/12/12/1316
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!